Y-Intercept (HK)’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18,818	Closed	-$35.4K	–	1524
2024 Q4	$35.4K	Buy	+18,818	New	+$35.4K	﹤0.01%	1122
2024 Q3	–	Sell	-158,259	Closed	-$185K	–	1692
2024 Q2	$185K	Buy	+158,259	New	+$185K	0.01%	1191